Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Hearne Michael S

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Hearne Michael S

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-03-07
Purchase
2019-03-11
5:42 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
140,000 $18.26 $2,556,316 13,086,038
(Indirect)
View
2018-12-27
Purchase
2018-12-31
5:17 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
63,700 $13.11 $835,107 12,946,038
(Indirect)
View
2018-12-20
Purchase
2018-12-26
6:21 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
60,000 $12.6 $755,857 12,882,338
(Indirect)
View
2018-12-14
Purchase
2018-12-18
5:58 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
40,000 $14.67 $586,639 12,822,338
(Indirect)
View
2018-12-11
Purchase
2018-12-13
8:18 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
20,000 $15.6 $312,073 12,782,338
(Indirect)
View
2018-12-06
Purchase
2018-12-10
6:24 pm
Odonate Therapeutics Inc. ODT TANG KEVIN C
TANG CAPITAL PARTNERS LP
TANG CAPITAL MANAGEMENT LLC
Lemkey John G
Hearne Michael S
CEO, 10% Owner
20,000 $14.79 $295,864 12,762,338
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-05-15
Option Award
2019-05-17
6:05 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
29 $18.87 13,086,038
(Direct)
View
2019-05-15
Option Award
2019-05-17
6:05 pm
N/A
2029-05-15
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
29 $22.2 13,086,038
(Direct)
View
2019-04-30
Option Award
2019-05-02
7:58 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
33 $16.71 13,086,038
(Direct)
View
2019-04-30
Option Award
2019-05-02
7:58 pm
N/A
2029-04-30
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
33 $19.66 13,086,038
(Direct)
View
2019-04-15
Option Award
2019-04-17
4:04 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
26 $21.24 13,086,038
(Direct)
View
2019-04-15
Option Award
2019-04-17
4:04 pm
N/A
2029-04-15
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
26 $24.99 13,086,038
(Direct)
View
2019-03-29
Option Award
2019-04-02
4:39 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
29 $18.79 13,086,038
(Direct)
View
2019-03-29
Option Award
2019-04-02
4:39 pm
N/A
2029-03-29
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
29 $22.11 13,086,038
(Direct)
View
2019-03-15
Option Award
2019-03-19
4:04 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
27 $20.19 13,086,038
(Direct)
View
2019-03-15
Option Award
2019-03-19
4:04 pm
N/A
2029-03-15
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
27 $23.75 13,086,038
(Direct)
View
2019-02-28
Option Award
2019-03-04
4:48 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
39 $14.01 12,946,038
(Direct)
View
2019-02-28
Option Award
2019-03-04
4:48 pm
N/A
2029-02-28
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
39 $16.48 12,946,038
(Direct)
View
2019-02-15
Option Award
2019-02-20
5:30 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
39 $14.04 12,946,038
(Direct)
View
2019-02-15
Option Award
2019-02-20
5:30 pm
N/A
2029-02-15
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
39 $16.52 12,946,038
(Direct)
View
2019-01-31
Option Award
2019-02-04
9:31 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
38 $14.08 12,946,038
(Direct)
View
2019-01-31
Option Award
2019-02-04
9:31 pm
N/A
2029-01-31
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
38 $16.57 12,946,038
(Direct)
View
2019-01-15
Option Award
2019-01-17
7:15 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $13.85 12,946,038
(Direct)
View
2019-01-15
Option Award
2019-01-17
7:15 pm
N/A
2029-01-15
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $16.29 12,946,038
(Direct)
View
2018-12-31
Option Award
2019-01-03
8:10 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
45 $11.97 12,946,038
(Direct)
View
2018-12-31
Option Award
2019-01-03
8:10 pm
N/A
2028-12-31
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
45,045 $14.08 12,946,038
(Direct)
View
2018-12-14
Option Award
2018-12-18
6:00 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
42 $12.85 12,822,338
(Direct)
View
2018-12-14
Option Award
2018-12-18
6:00 pm
N/A
2028-12-14
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
42 $15.12 12,822,338
(Direct)
View
2018-11-30
Option Award
2018-12-04
6:27 pm
N/A
N/A
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $13.4 12,742,338
(Direct)
View
2018-11-30
Option Award
2018-12-04
6:27 pm
N/A
2028-11-30
Odonate Therapeutics Inc. ODT Hearne Michael S
CFO
40 $15.76 12,742,338
(Direct)
View